Randomized trial of aspirin, sibrafiban, or both for secondary prevention after acute coronary syndromes.
摘要:
Combining aspirin with LDS did not improve outcomes after acute coronary syndromes and caused more bleeding compared with aspirin alone. There was a trend toward increased mortality in this group and a significant increase in the high-dose arm.
展开
DOI:
10.1016/S1062-1458(01)00370-1
被引量:
年份:
2001
相似文献
参考文献
引证文献
来源期刊
Acc Current Journal Review
September–October 2001
引用走势
2002
被引量:34
辅助模式
0
引用
文献可以批量引用啦~
欢迎点我试用!